ModivCare PE Ratio 2010-2024 | MODV
Current and historical p/e ratio for ModivCare (MODV) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. ModivCare PE ratio as of February 21, 2025 is 4.46.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| ModivCare PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-02-21 | 5.05 | 0.00 | |
| 2024-09-30 | 14.28 | $-12.88 | 0.00 |
| 2024-06-30 | 26.24 | $-11.31 | 0.00 |
| 2024-03-31 | 23.45 | $-15.71 | 0.00 |
| 2023-12-31 | 43.99 | $-14.42 | 0.00 |
| 2023-09-30 | 31.51 | $-14.54 | 0.00 |
| 2023-06-30 | 45.21 | $-16.27 | 0.00 |
| 2023-03-31 | 84.08 | $-5.05 | 0.00 |
| 2022-12-31 | 89.73 | $-5.31 | 0.00 |
| 2022-09-30 | 99.68 | $-3.86 | 0.00 |
| 2021-12-31 | 148.29 | $-0.52 | 0.00 |
| 2021-09-30 | 181.62 | $1.51 | 120.28 |
| 2021-06-30 | 170.07 | $4.55 | 37.38 |
| 2021-03-31 | 148.12 | $3.83 | 38.67 |
| 2020-12-31 | 138.63 | $1.54 | 90.02 |
| 2020-09-30 | 92.91 | $2.76 | 33.66 |
| 2022-06-30 | 84.50 | $-0.29 | 0.00 |
| 2020-06-30 | 78.91 | $-0.06 | 0.00 |
| 2020-03-31 | 54.88 | $0.70 | 78.40 |
| 2019-12-31 | 59.18 | $-0.28 | 0.00 |
| 2019-09-30 | 59.46 | $0.23 | 258.52 |
| 2019-06-30 | 57.34 | $-1.91 | 0.00 |
| 2022-03-31 | 115.39 | $-1.28 | 0.00 |
| 2019-03-31 | 66.62 | $-2.25 | 0.00 |
| 2018-12-31 | 60.02 | $-1.92 | 0.00 |
| 2018-09-30 | 67.28 | $2.16 | 31.15 |
| 2018-06-30 | 78.55 | $2.63 | 29.87 |
| 2018-03-31 | 69.14 | $3.76 | 18.39 |
| 2017-12-31 | 59.34 | $3.07 | 19.33 |
| 2017-09-30 | 54.08 | $5.58 | 9.69 |
| 2017-06-30 | 50.61 | $4.65 | 10.88 |
| 2017-03-31 | 44.44 | $4.68 | 9.50 |
| 2016-12-31 | 38.05 | $5.15 | 7.39 |
| 2016-09-30 | 48.63 | $4.30 | 11.31 |
| 2016-06-30 | 44.88 | $3.94 | 11.39 |
| 2016-03-31 | 51.07 | $3.99 | 12.80 |
| 2015-12-31 | 46.92 | $4.24 | 11.07 |
| 2015-09-30 | 43.58 | $0.62 | 70.29 |
| 2015-06-30 | 44.28 | $1.05 | 42.17 |
| 2015-03-31 | 53.12 | $1.25 | 42.50 |
| 2014-12-31 | 36.44 | $1.37 | 26.60 |
| 2014-09-30 | 48.38 | $1.16 | 41.71 |
| 2014-06-30 | 36.59 | $1.39 | 26.32 |
| 2014-03-31 | 28.28 | $1.36 | 20.79 |
| 2013-12-31 | 25.72 | $1.41 | 18.24 |
| 2013-09-30 | 28.69 | $1.39 | 20.64 |
| 2013-06-30 | 29.09 | $1.23 | 23.65 |
| 2013-03-31 | 18.49 | $0.91 | 20.32 |
| 2012-12-31 | 16.99 | $0.65 | 26.14 |
| 2012-09-30 | 12.99 | $0.65 | 19.98 |
| 2012-06-30 | 13.71 | $0.71 | 19.31 |
| 2012-03-31 | 15.51 | $0.96 | 16.16 |
| 2011-12-31 | 13.76 | $1.07 | 12.86 |
| 2011-09-30 | 10.65 | $1.18 | 9.03 |
| 2011-06-30 | 12.65 | $1.25 | 10.12 |
| 2011-03-31 | 14.98 | $1.43 | 10.48 |
| 2010-12-31 | 16.07 | $1.75 | 9.18 |
| 2010-09-30 | 16.39 | $1.84 | 8.91 |
| 2010-06-30 | 14.00 | $1.96 | 7.14 |
| 2010-03-31 | 15.19 | $1.82 | 8.35 |
| 2009-12-31 | 15.80 | $1.60 | 9.88 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.082B | $2.756B |
| ModivCare Inc. is a technology-enabled healthcare services company. It provides a suite of integrated supportive care solutions for public and private payors and their patients. ModivCare Inc., formerly known as The Providence Service Corporation, is based in DENVER. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.052B | 27.37 |
| Elevance Health (ELV) | United States | $90.846B | 11.88 |
| CVS Health (CVS) | United States | $83.717B | 12.25 |
| Cencora (COR) | United States | $47.591B | 17.27 |
| DiDi Global (DIDIY) | China | $23.087B | 0.00 |
| Natera (NTRA) | United States | $22.788B | 0.00 |
| ICON (ICLR) | Ireland | $15.783B | 14.04 |
| Doximity (DOCS) | United States | $14.316B | 74.45 |
| BioMerieux (BMXMF) | France | $14.074B | 0.00 |
| Revvity (RVTY) | United States | $13.997B | 23.47 |
| Viatris (VTRS) | United States | $13.046B | 4.02 |
| Solventum (SOLV) | United States | $12.780B | 0.00 |
| Avantor (AVTR) | United States | $12.038B | 17.68 |
| CochLear (CHEOY) | Australia | $11.471B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.479B | 27.23 |
| HealthEquity (HQY) | United States | $9.860B | 49.47 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.450B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.815B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.437B | 15.99 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.745B | 26.29 |
| Organon (OGN) | United States | $3.938B | 4.01 |
| Sotera Health (SHC) | United States | $3.861B | 20.65 |
| BrightSpring Health Services (BTSG) | United States | $3.639B | 77.41 |
| Surgery Partners (SGRY) | United States | $3.282B | 37.42 |
| GeneDx Holdings (WGS) | United States | $3.058B | 371.03 |
| Concentras Parent (CON) | United States | $2.973B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.699B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.371B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.078B | 0.00 |
| Progyny (PGNY) | United States | $2.017B | 40.85 |
| PACS (PACS) | United States | $2.006B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.955B | 51.30 |
| Premier (PINC) | United States | $1.711B | 10.96 |
| Agilon Health (AGL) | United States | $1.471B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| CareDx (CDNA) | United States | $1.325B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.212B | 11.86 |
| Establishment Labs Holdings (ESTA) | $1.010B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.908B | 6.14 |
| Embecta (EMBC) | United States | $0.899B | 6.16 |
| Auna S.A (AUNA) | Luxembourg | $0.633B | 0.00 |
| DocGo (DCGO) | United States | $0.562B | 21.19 |
| Sonida Senior Living (SNDA) | United States | $0.499B | 0.00 |
| SBC Medicals (SBC) | United States | $0.483B | 0.00 |
| MultiPlan (MPLN) | United States | $0.476B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.453B | 0.00 |
| Enhabit (EHAB) | United States | $0.440B | 38.09 |
| Nutex Health (NUTX) | United States | $0.352B | 0.00 |
| LifeMD (LFMD) | United States | $0.345B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.308B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.294B | 7.71 |
| Beauty Health (SKIN) | United States | $0.210B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.183B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.144B | 0.00 |
| Biodesix (BDSX) | United States | $0.138B | 0.00 |
| So-Young (SY) | China | $0.118B | 19.98 |
| IceCure Medical (ICCM) | Israel | $0.086B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| Oncology Institute (TOI) | United States | $0.073B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.60 |
| Singular Genomics Systems (OMIC) | United States | $0.051B | 0.00 |
| OncoCyte (OCX) | United States | $0.048B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.022B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.020B | 0.00 |
| KindlyMD (KDLY) | United States | $0.016B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |